World-First Cancer Vaccine Cuts Melanoma Recurrence or Death Risk by 42% in Landmark Trial

"This has not been achieved before in the history of cancer drug development."

ScienceAlert stories are written, fact-checked, and edited by humans, never generated by AI. Don't miss a story, subscribe here.

from ScienceAlert https://ift.tt/nwRE01G